Adjuvant Chemotherapy After Preoperative Chemoradiotherapy to Treat Rectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

322

Participants

Timeline

Start Date

November 1, 2008

Primary Completion Date

June 30, 2013

Study Completion Date

September 5, 2014

Conditions
Rectal Cancer
Interventions
DRUG

Adjuvant FL

5-Fluorouracil 380 mg/m2, leucovorin 20 mg/m2 on D1-5 q 4 weeks X 4 cycles

DRUG

Adjuvant FOLFOX

oxaliplatin 85 mg/m2, leucovorin 200 mg/m2 on D1, 5-Fluorouracil bolus 400 mg/m2 on D1, 5-Fluorouracil continuous infusion 2400 mg/m2 for 46 hours q 2 weeks X 8 cycles

Trial Locations (6)

Unknown

National Cancer Center, Goyang

Seoul National Unversity Bundang Hospital, Seongnam

Asan Medical Center, Seoul

Samsung Medical Center, Seoul

Seoul National University Hospital, Seoul

Yeonsei University Hosptial, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER

NCT00807911 - Adjuvant Chemotherapy After Preoperative Chemoradiotherapy to Treat Rectal Cancer | Biotech Hunter | Biotech Hunter